Fratricide-resistant CD7 CAR-T therapy by NUS proves effective in treating relapsed or refractory T-cell leukaemia ...

Analyzing the genetics of patients that responded well to checkpoint blockade revealed mutations in the gene Asxl1 in immune T cells. Disrupting the Asxl1 gene in T cells enhanced response to immune ...

CAR T-cell therapy offers the "holy grail" of precision therapy in lung cancer, but it is biologically challenging and poses significant problems, according to experts.

New research from St. Jude Children's Research Hospital and colleagues found that disrupting Asxl1, a gene in T cells, ...

In the clinical battle against leukemia, recent breakthroughs in chimeric antigen receptor T cells (CAR T) have given ...

New life begins with the meeting of sperm and egg. But how they fuse together has long been a mystery. New research by ...

Matica Biotechnology, a leading Texas-based viral vector Contract Development and Manufacturing Organization (CDMO), has ...

New York Governor Kathy Hochul has considered a statewide ban on smart devices in schools, but many parents, students, and ...

Imagine a world where your own immune cells are transformed into cancer-fighting superheroes. This is the promise of CAR-T ...

Blood cancer is one of the most dangerous in the world, but advancements in treatment are changing to landscape for patients.

Players have received a much-awaited (but unofficial) update on Splinter Cell remake‘s release date window, and it’s not ...

A new cell therapy, targeting CD7 in leukemia cells, gives a potentially effective treatment for patients with T-cell acute ...